バイオロジクスの世界市場レポート 2024

バイオロジクスの市場規模は、今後数年間で急速に成長すると予想されています。 2028年には10.0%の年間複合成長率（CAGR）で6,663億1,000万米ドルに成長すると予想されます。予測される成長は、資金の増加、技術の進歩、ヘルスケアアクセスの改善、経口バイオロジクスの強力な研究開発活動、注射よりも錠剤の好み、バイオロジクスのパイプラインの成長によって促進されます。主な動向としては、バイオロジクスの開発強化のための改正規制の活用、これらの医薬品の需要を活用する方向への移行、革新的なバイオロジクス研究開発への投資の増加、複雑な疾患を治療するためのバイオロジクスに焦点を当てた調査が挙げられます。

個別化医療に対する需要の高まりは、確かにバイオロジクス市場の成長を支える重要な原動力となっています。個別化医療は精密医療としても知られ、個々の患者の特性に合わせて治療とヘルスケアを調整します。このアプローチにより、患者固有の遺伝的および臨床的プロファイルに基づいて生物学的治療をカスタマイズすることが可能になり、ヘルスケア業界に大きな変革をもたらします。 Personalized Medicine Coalitionのレポートで証明されているように、2021年の新薬承認のかなりの部分、約35%が個別化医療であり、より広範な製薬情勢におけるこの分野の重要性の高まりを示しています。したがって、この個別化医療に対する需要の急増は、バイオロジクス市場の成長を促進すると予想されます。

この時期、テクノロジーは市場拡大の継続的な原動力として際立っています。特に生理学シミュレーションモデリングは重要な発展の準備が整っており、市場の成長に貢献すると予想されています。この分野の進歩は効率の向上を約束しており、バイオロジクス市場内の企業はそのような進歩から恩恵を受ける可能性があります。注目すべき例には、イーライリリーやファイザーなどの製薬大手によるAmazonのElastic Compute Cloud（EC2）プラットフォームの採用が含まれます。これらの企業は、初期の創薬におけるシミュレーションモデルの実行にこのテクノロジーを活用し、シミュレーションに必要な時間を大幅に短縮しています。たとえば、従来は数週間かかっていたタスクが数時間以内に完了できるようになりました。 Lillyのオープンイノベーション創薬プログラムなどの取り組みは、バイオロジクスの研究開発を強化する取り組みをさらに強調しています。これらの技術の進歩により、プロセスが合理化され、コストが削減され、バイオロジクスの開発段階が加速されることが期待されており、企業はより迅速に製品を市場に投入できるようになります。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 製品/サービス分析- 製品/サービスの例

• バイオロジクスのサプライチェーン分析
  • バイオロジクスリソース
  • バイオロジクスメーカー
  • バイオロジクスの販売業者および小売業者
  • バイオロジクスのエンドユーザー
• バイオロジクスの顧客情報

第4章 市場動向と戦略

第5章 マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第6章 世界市場規模と成長

• 世界の市場促進要因と抑制要因
  • 市場促進要因
  • 市場抑制要因
• 世界の市場規模実績と成長、2018年～2023年
• 世界の市場規模予測と成長、2023年～2028年、2033年

第7章 市場セグメンテーション

• 世界のバイオロジクス市場、タイプ別セグメンテーション、実績および予測、2018-2023、2023-2028年、2033年
• モノクローナル抗体（MAbS）
• 治療用タンパク質
• ワクチン
• 世界のバイオロジクス市場、医薬品分類別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• ブランド医薬品
• ジェネリック医薬品
• 世界のバイオロジクス市場、投与経路別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 経口
• 非経口
• その他
• 世界のバイオロジクス市場、購入モード別セグメンテーション、実績および予測、2018-2023、2023-2028年、2033年
• 処方箋ベースの医薬品
• 市販薬
• 世界のバイオロジクス市場、流通チャネル別セグメンテーション、実績および予測、2018-2023、2023-2028年、2033年
• 病院薬局
• 小売薬局/ドラッグストア
• その他

第8章 地域および国の分析

• 世界のバイオロジクス市場、地域別、実績および予測、2018-2023年、2023-2028年、2033年
• 世界のバイオロジクス市場、国別、実績および予測、2018-2023、2023-2028年、2033年

第9章 アジア太平洋市場

第10章 中国市場

第11章 インド市場

第12章 日本市場

第13章 オーストラリア市場

第14章 インドネシア市場

第15章 韓国市場

第16章 バングラデシュ市場

第17章 タイ市場

第18章 ベトナム市場

第19章 マレーシア市場

第20章 シンガポール市場

第21章 フィリピン市場

第22章 香港市場

第23章 ニュージーランド市場

第24章 西欧市場

第25章 英国市場

第26章 ドイツ市場

第27章 フランス市場

第28章 イタリア市場

第29章 スペイン市場

第30章 オーストリア市場

第31章 ベルギー市場

第32章 デンマーク市場

第33章 フィンランド市場

第34章 アイルランド市場

第35章 オランダ市場

第36章 ノルウェー市場

第37章 ポルトガル市場

第38章 スウェーデン市場

第39章 スイス市場

第40章 東欧市場

第41章 ロシア市場

第42章 チェコ共和国の市場

第43章 ポーランド市場

第44章 ルーマニア市場

第45章 ウクライナ市場

第46章 北米市場

第47章 米国市場

第48章 カナダ市場

第49章 メキシコ市場

第50章 南米市場

第51章 ブラジル市場

第52章 チリ市場

第53章 アルゼンチン市場

第54章 コロンビア市場

第55章 ペルー市場

第56章 中東市場

第57章 サウジアラビア市場

第58章 イスラエル市場

第59章 イラン市場

第60章 トルコ市場

第61章 アラブ首長国連邦市場

第62章 アフリカ市場

第63章 エジプト市場

第64章 ナイジェリア市場

第65章 南アフリカ市場

第66章 競合情勢と企業プロファイル

• バイオロジクス市場の競合情勢
• バイオロジクス市場の企業プロファイル
  • Merck &Co., Inc.
  • AbbVie Inc.
  • F. Hoffmann-La Roche AG
  • Johnson &Johnson
  • Pfizer Inc.

第67章 その他の大手および革新的な企業

• Bristol Myers Squibb Company
• Sanofi SA
• GlaxoSmithKline Plc.
• Eli Lilly and Company
• Amgen Inc.
• Wockhardt
• Zydus Cadilla
• Asahi Glass Co. Ltd.
• China Biologic Products Holdings Inc.
• China Regenerative Medicine International
• ABLbio
• Adimmune
• Henlius
• Innovent Biologics
• Bio-Thera

第68章 競合ベンチマーキング

第69章 競合ダッシュボード

第70章 主要な合併と買収

第71章 将来の見通しと可能性の分析

第72章 付録

Biologics are medications derived from organic materials and are utilized to treat a diverse range of illnesses, particularly immune-related conditions such as Crohn's disease, psoriasis, ankylosing spondylitis, and rheumatoid arthritis. One intriguing aspect is that biologics are sourced from various natural materials, including carbohydrates, proteins, nucleic acids, or complex mixtures of these substances.

The primary types of biologics include monoclonal antibodies (MAbs), therapeutic proteins, and vaccines. Monoclonal antibodies, or mAbs, are engineered in laboratories to target specific infections. These biologics can be administered through various routes, including oral, parenteral, and others, and are distributed through channels such as hospital pharmacies, retail pharmacies/drug stores, and others.

The biologics market research report is one of a series of new reports from The Business Research Company that provides biologics market statistics, including biologics industry global market size, regional shares, competitors with a biologics market share, detailed biologics market segments, market trends, and opportunities, and any further data you may need to thrive in the biologics industry. This biologics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The biologics market size has grown strongly in recent years. It will grow from $416.65 billion in 2023 to $454.4 billion in 2024 at a compound annual growth rate (CAGR) of 9.1%. The growth observed during the historic period can be attributed to several factors, including an aging population, government initiatives, the ability to command high prices, and an increased need for immunology.

The biologics market size is expected to see rapid growth in the next few years. It will grow to $666.31 billion in 2028 at a compound annual growth rate (CAGR) of 10.0%. The forecasted growth is driven by increased funding, technological advancements, improved healthcare access, robust research and development activities for oral biologics, a preference for pills over injections, and a growing pipeline of biologics. Key trends include leveraging revised regulations for enhanced biologics development, a shift towards capitalizing on the demand for these drugs, increased investment in innovative biologics R&D, and research focused on biologics for treating complex diseases.

The increasing demand for personalized medicine is indeed a key driver behind the growth of the biologics market. Personalized medicine, also known as precision medicine, tailors medical treatment and healthcare to individual patient characteristics. This approach allows for the customization of biologic treatments based on a patient's specific genetic and clinical profile, marking a transformative shift in the healthcare industry. As evidenced by the Personalized Medicine Coalition's report, a substantial portion, approximately 35%, of new drug approvals in 2021 were personalized medicines, showcasing the rising significance of this sector within the broader pharmaceutical landscape. Consequently, this surge in demand for personalized medicine is expected to drive the growth of the biologics market.

Technology stands out as a continued driving force behind market expansion in this period. Physiology simulation modeling, in particular, is poised for significant development and is anticipated to contribute to market growth. Advances in this field promise greater efficiencies, and companies within the biologics market are likely to benefit from such advancements. Notable instances include the adoption of Amazon's Elastic Compute Cloud (EC2) platform by pharmaceutical giants such as Eli Lilly and Pfizer. These companies utilize this technology for conducting simulation models in early drug discovery, significantly reducing the time required for simulations. For instance, tasks that traditionally took weeks can now be completed within hours. Initiatives such as Lilly's Open Innovation Drug Discovery program further underscore efforts to enhance biologics research and development. These technological advancements are expected to streamline processes, lower costs, and accelerate the development phase of biologics, enabling companies to introduce their products to market more swiftly.

The focus of major companies in the biologics industry on developing innovative products, such as oncology biosimilars, reflects their strategic initiatives to strengthen market positions and gain competitive advantages. Oncology biosimilars, specifically designed to treat cancer, are akin to existing biologic drugs and offer highly similar alternatives in terms of efficacy and safety. An example of this pursuit is seen in the collaboration between Biocon Biologics Limited and Viatris Inc., which led to the launch of Abevmy in Canada in May 2022. Abevmy is an oncology biosimilar utilized for cancer treatment, exhibiting similarity to an already authorized biological medicine.

The revisions made by the US Food and Drug Administration (FDA) in its regulations concerning biologics signify a shift toward eliminating outdated requirements. The alterations allow drug manufacturers to adopt new manufacturing technologies and testing capabilities. Specifically, the FDA has amended regulations to enable the sourcing of standard preparations, critical in ensuring the safety, purity, and potency of biologics, from sources beyond the FDA's Center for Biologics Evaluation and Research (CBER). Additionally, the FDA has removed the minimal potency limits rule (Section 610.21 of FDA code) pertaining to certain antibodies and antigens. Furthermore, updates in regulations (Section 610.53 of FDA code) concerning storage periods and conditions for biologics have been introduced. These regulatory amendments aim to enhance flexibility and promote the adoption of contemporary scientific technologies in the manufacturing processes of licensed biological products, fostering innovation and progress in the biologics industry.

Major companies operating in the biologics market report are Merck & Co., Inc., AbbVie Inc., F. Hoffmann-La Roche AG, Johnson & Johnson, Pfizer Inc., Bristol Myers Squibb Company, Sanofi S.A., GlaxoSmithKline Plc., Eli Lilly and Company, Amgen Inc., Wockhardt, Zydus Cadilla, Asahi Glass Co. Ltd., China Biologic Products Holdings Inc., China Regenerative Medicine International, ABLbio, Adimmune, Henlius, Innovent Biologics, Bio-Thera, Hisun Pharma, 3SBio, Beijing ShuangLu Pharmaceuticals, Qilu Pharmaceutical, Shanghai Fosun Pharmaceuticals, Biocon, Dr.Reddy's, Mylan, Kyowa Hakko Kirin, Takeda, Mitsubishi Tanabe, AGC Biologics, Tonghua Dongbao Pharmaceutical Co., China Regenerative Medicine International, Shanghai Fosun Pharmaceuticals, Bayer AG, Novartis AG, BiosanaPharma, WuXi, Teva UK Limited, AstraZeneca, Abbott Laboratories, Vectura Group, Fujifilm, Lonza, Seqens, Piramal Pharma Solutions, Corden Pharma, Procos SpA and BSP Pharmaceuticals., Microgen, Geropharm, Valenta, NovaMedica, SynBi, Rani Therapeutics, Emisphere Technologies Inc., Enteris BioPharma, Allena Pharmaceuticals, Biogen Inc., Emisphere Technologies Inc., Biogen Inc., Novartis, Apotex, Gilead Sciences, Bayer, Abbott Laboratories

North America was the largest region in the biologics market in 2023. Middle East is expected to be the fastest growing region in the forecast period. The regions covered in the biologics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the biologics market report are Australia, China, India, Indonesia, Japan, South Korea, Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, USA, Canada, Mexico, Brazil, Chile, Argentina, Colombia, Peru, France, Germany, UK, Austria, Belgium, Denmark, Finland, Ireland, Italy, Netherlands, Norway, Portugal, Spain, Sweden, Switzerland, Russia, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa

The biologics market consists of sales of tumor necrosis factor inhibitors, Interleukin inhibitors, B-cells inhibitors, and T-cells inhibitors. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Biologics Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on biologics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for biologics? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The biologics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

• 1) By Type: Monoclonal Antibodies (MAbS); Therapeutic Proteins; Vaccines
• 2) By Drug Classification: Branded Drugs; Generic Drugs
• 3) By Route Of Administration: Oral; Other Route Of Administration
• 4) By Mode Of Purchase: Prescription-Based Drugs; Over-The-Counter Drugs
• 5) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies/ Drug Stores; Other Distribution Channels
• Subsegments Covered: Anti-Cancer MAbS; Immunological MAbS; Anti-Infective Monoclonal Antibodies (MAbs); Neuropharmacological MABS; Cardiovascular And Cerebrovascular MAbS; Other Monoclonal Antibodies (MAbs); Metabolic Disorders Therapeutic Proteins; Cancer Therapeutic Proteins; Cardiovascular Therapeutic Proteins; Immunological Therapeutic Proteins; Other Therapeutic Proteins; Anti-Infective Vaccines; Autoimmunity Vaccines; Other Vaccines
• Companies Mentioned: Merck & Co., Inc.; AbbVie Inc.; F. Hoffmann-La Roche AG; Johnson & Johnson; Pfizer Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Biologics Market Characteristics

3. Biologics Product/Service Analysis -Product/Service Examples

• 3.1. Biologics Supply Chain Analysis
  • 3.1.1. Biologics Resources
  • 3.1.2. Biologics Manufacturers
  • 3.1.3. Biologics Distributors and Retailers
  • 3.1.4. Biologics End Users
• 3.2. Biologics Customer Information

4. Biologics Market Trends And Strategies

5. Biologics Market - Macro Economic Scenario

• 5.1. Impact Of High Inflation On The Market
• 5.2. Ukraine-Russia War Impact On The Market
• 5.3. COVID-19 Impact On The Market

6. Global Biologics Market Size and Growth

• 6.1. Global Biologics Market Drivers and Restraints
  • 6.1.1. Drivers Of The Market
  • 6.1.2. Restraints Of The Market
• 6.2. Global Biologics Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 6.3. Global Biologics Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

7. Biologics Market Segmentation

• 7.1. Global Biologics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Monoclonal Antibodies (MAbS)
• Therapeutic Proteins
• Vaccines
• 7.2. Global Biologics Market, Segmentation By Drug Classification, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Branded Drugs
• Generic Drugs
• 7.3. Global Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Oral
• Parenteral
• Other Route Of Administration
• 7.4. Global Biologics Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Prescription-Based Drugs
• Over-The-Counter Drugs
• 7.5. Global Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Hospital Pharmacies
• Retail Pharmacies/ Drug Stores
• Other Distribution Channels

8. Biologics Market Regional And Country Analysis

• 8.1. Global Biologics Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.2. Global Biologics Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. Asia-Pacific Biologics Market

• 9.1. Asia-Pacific Biologics Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 9.2. Asia-Pacific Biologics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 9.3. Asia-Pacific Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 9.4. Asia-Pacific Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

10. China Biologics Market

• 10.1. China Biologics Market Overview
• 10.2. China Biologics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 10.3. China Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 10.4. China Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

11. India Biologics Market

• 11.1. India Biologics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.2. India Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. India Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Japan Biologics Market

• 12.1. Japan Biologics Market Overview
• 12.2. Japan Biologics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Japan Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.4. Japan Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Australia Biologics Market

• 13.1. Australia Biologics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Australia Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Australia Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. Indonesia Biologics Market

• 14.1. Indonesia Biologics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.2. Indonesia Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. Indonesia Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. South Korea Biologics Market

• 15.1. South Korea Biologics Market Overview
• 15.2. South Korea Biologics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. South Korea Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. South Korea Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. Bangladesh Biologics Market

• 16.1. Bangladesh, Biologics Historic Market, 2018 - 2023, $ Billion
• 16.2. Bangladesh, Biologics Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

17. Thailand Biologics Market

• 17.1. Thailand, Biologics Historic Market, 2018 - 2023, $ Billion
• 17.2. Thailand, Biologics Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

18. Vietnam Biologics Market

• 18.1. Vietnam, Biologics Historic Market, 2018 - 2023, $ Billion
• 18.2. Vietnam, Biologics Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

19. Malaysia Biologics Market

• 19.1. Malaysia, Biologics Historic Market, 2018 - 2023, $ Billion
• 19.2. Malaysia, Biologics Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

20. Singapore Biologics Market

• 20.1. Singapore, Biologics Historic Market, 2018 - 2023, $ Billion
• 20.2. Singapore, Biologics Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

21. Philippines Biologics Market

• 21.1. Philippines, Biologics Historic Market, 2018 - 2023, $ Billion
• 21.2. Philippines, Biologics Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

22. Hong kong Biologics Market

• 22.1. Hong Kong, Biologics Historic Market, 2018 - 2023, $ Billion
• 22.2. Hong Kong, Biologics Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

23. New Zealand Biologics Market

• 23.1. New Zealand, Biologics Historic Market, 2018 - 2023, $ Billion
• 23.2. New Zealand, Biologics Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

24. Western Europe Biologics Market

• 24.1. Western Europe Biologics Market Overview
• 24.2. Western Europe Biologics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. Western Europe Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. Western Europe Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. UK Biologics Market

• 25.1. UK Biologics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.2. UK Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. UK Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. Germany Biologics Market

• 26.1. Germany Biologics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.2. Germany Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. Germany Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. France Biologics Market

• 27.1. France Biologics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. France Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. France Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Italy Biologics Market

• 28.1. Italy Biologics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.2. Italy Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Italy Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Spain Biologics Market

• 29.1. Spain Biologics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.2. Spain Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Spain Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Austria Biologics Market

• 30.1. Austria, Biologics Historic Market, 2018 - 2023, $ Billion
• 30.2. Austria, Biologics Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

31. Belgium Biologics Market

• 31.1. Belgium, Biologics Historic Market, 2018 - 2023, $ Billion
• 31.2. Belgium, Biologics Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

32. Denmark Biologics Market

• 32.1. Denmark, Biologics Historic Market, 2018 - 2023, $ Billion
• 32.2. Denmark, Biologics Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

33. Finland Biologics Market

• 33.1. Finland, Biologics Historic Market, 2018 - 2023, $ Billion
• 33.2. Finland, Biologics Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

34. Ireland Biologics Market

• 34.1. Ireland, Biologics Historic Market, 2018 - 2023, $ Billion
• 34.2. Ireland, Biologics Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

35. Netherlands Biologics Market

• 35.1. Netherlands, Biologics Historic Market, 2018 - 2023, $ Billion
• 35.2. Netherlands, Biologics Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

36. Norway Biologics Market

• 36.1. Norway, Biologics Historic Market, 2018 - 2023, $ Billion
• 36.2. Norway, Biologics Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

37. Portugal Biologics Market

• 37.1. Portugal, Biologics Historic Market, 2018 - 2023, $ Billion
• 37.2. Portugal, Biologics Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

38. Sweden Biologics Market

• 38.1. Sweden, Biologics Historic Market, 2018 - 2023, $ Billion
• 38.2. Sweden, Biologics Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

39. Switzerland Biologics Market

• 39.1. Switzerland, Biologics Historic Market, 2018 - 2023, $ Billion
• 39.2. Switzerland, Biologics Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

40. Eastern Europe Biologics Market

• 40.1. Eastern Europe Biologics Market Overview
• 40.2. Eastern Europe Biologics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 40.3. Eastern Europe Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 40.4. Eastern Europe Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

41. Russia Biologics Market

• 41.1. Russia Biologics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 41.2. Russia Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 41.3. Russia Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

42. Czech Republic Biologics Market

• 42.1. Czech Republic, Biologics Historic Market, 2018 - 2023, $ Billion
• 42.2. Czech Republic, Biologics Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

43. Poland Biologics Market

• 43.1. Poland, Biologics Historic Market, 2018 - 2023, $ Billion
• 43.2. Poland, Biologics Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

44. Romania Biologics Market

• 44.1. Romania, Biologics Historic Market, 2018 - 2023, $ Billion
• 44.2. Romania, Biologics Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

45. Ukraine Biologics Market

• 45.1. Ukraine, Biologics Historic Market, 2018 - 2023, $ Billion
• 45.2. Ukraine, Biologics Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

46. North America Biologics Market

• 46.1. North America Biologics Market Overview
• 46.2. North America Biologics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 46.3. North America Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 46.4. North America Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

47. USA Biologics Market

• 47.1. USA Biologics Market Overview
• 47.2. USA Biologics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 47.3. USA Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 47.4. USA Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

48. Canada Biologics Market

• 48.1. Canada Biologics Market Overview
• 48.2. Canada Biologics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 48.3. Canada Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 48.4. Canada Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

49. Mexico Biologics Market

• 49.1. Mexico, Biologics Historic Market, 2018 - 2023, $ Billion
• 49.2. Mexico, Biologics Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

50. South America Biologics Market

• 50.1. South America Biologics Market Overview
• 50.2. South America Biologics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 50.3. South America Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 50.4. South America Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

51. Brazil Biologics Market

• 51.1. Brazil Biologics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 51.2. Brazil Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 51.3. Brazil Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

52. Chile Biologics Market

• 52.1. Chile, Biologics Historic Market, 2018 - 2023, $ Billion
• 52.2. Chile, Biologics Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

53. Argentina Biologics Market

• 53.1. Argentina, Biologics Historic Market, 2018 - 2023, $ Billion
• 53.2. Argentina, Biologics Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

54. Colombia Biologics Market

• 54.1. Colombia, Biologics Historic Market, 2018 - 2023, $ Billion
• 54.2. Colombia, Biologics Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

55. Peru Biologics Market

• 55.1. Peru, Biologics Historic Market, 2018 - 2023, $ Billion
• 55.2. Peru, Biologics Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

56. Middle East Biologics Market

• 56.1. Middle East Biologics Market Overview
• 56.2. Middle East Biologics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 56.3. Middle East Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 56.4. Middle East Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

57. Saudi Arabia Biologics Market

• 57.1. Saudi Arabia, Biologics Historic Market, 2018 - 2023, $ Billion
• 57.2. Saudi Arabia, Biologics Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

58. Israel Biologics Market

• 58.1. Israel, Biologics Historic Market, 2018 - 2023, $ Billion
• 58.2. Israel, Biologics Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

59. Iran Biologics Market

• 59.1. Iran, Biologics Historic Market, 2018 - 2023, $ Billion
• 59.2. Iran, Biologics Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

60. Turkey Biologics Market

• 60.1. Turkey, Biologics Historic Market, 2018 - 2023, $ Billion
• 60.2. Turkey, Biologics Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

61. United Arab Emirates Biologics Market

• 61.1. United Arab Emirates, Biologics Historic Market, 2018 - 2023, $ Billion
• 61.2. United Arab Emirates, Biologics Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

62. Africa Biologics Market

• 62.1. Africa Biologics Market Overview
• 62.2. Africa Biologics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 62.3. Africa Biologics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 62.4. Africa Biologics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

63. Egypt Biologics Market

• 63.1. Egypt, Biologics Historic Market, 2018 - 2023, $ Billion
• 63.2. Egypt, Biologics Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

64. Nigeria Biologics Market

• 64.1. Nigeria, Biologics Historic Market, 2018 - 2023, $ Billion
• 64.2. Nigeria, Biologics Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

65. South Africa Biologics Market

• 65.1. South Africa, Biologics Historic Market, 2018 - 2023, $ Billion
• 65.2. South Africa, Biologics Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

66. Biologics Market Competitive Landscape And Company Profiles

• 66.1. Biologics Market Competitive Landscape
• 66.2. Biologics Market Company Profiles
  • 66.2.1. Merck & Co., Inc.
    • 66.2.1.1. Overview
    • 66.2.1.2. Products and Services
    • 66.2.1.3. Strategy
    • 66.2.1.4. Financial Performance
  • 66.2.2. AbbVie Inc.
    • 66.2.2.1. Overview
    • 66.2.2.2. Products and Services
    • 66.2.2.3. Strategy
    • 66.2.2.4. Financial Performance
  • 66.2.3. F. Hoffmann-La Roche AG
    • 66.2.3.1. Overview
    • 66.2.3.2. Products and Services
    • 66.2.3.3. Strategy
    • 66.2.3.4. Financial Performance
  • 66.2.4. Johnson & Johnson
    • 66.2.4.1. Overview
    • 66.2.4.2. Products and Services
    • 66.2.4.3. Strategy
    • 66.2.4.4. Financial Performance
  • 66.2.5. Pfizer Inc.
    • 66.2.5.1. Overview
    • 66.2.5.2. Products and Services
    • 66.2.5.3. Strategy
    • 66.2.5.4. Financial Performance

67. Biologics Market Other Major And Innovative Companies

• 67.1. Bristol Myers Squibb Company
• 67.2. Sanofi S.A.
• 67.3. GlaxoSmithKline Plc.
• 67.4. Eli Lilly and Company
• 67.5. Amgen Inc.
• 67.6. Wockhardt
• 67.7. Zydus Cadilla
• 67.8. Asahi Glass Co. Ltd.
• 67.9. China Biologic Products Holdings Inc.
• 67.10. China Regenerative Medicine International
• 67.11. ABLbio
• 67.12. Adimmune
• 67.13. Henlius
• 67.14. Innovent Biologics
• 67.15. Bio-Thera

68. Global Biologics Market Competitive Benchmarking

69. Global Biologics Market Competitive Dashboard

70. Key Mergers And Acquisitions In The Biologics Market

71. Biologics Market Future Outlook and Potential Analysis

• 71.1 Biologics Market In 2028 - Countries Offering Most New Opportunities
• 71.2 Biologics Market In 2028 - Segments Offering Most New Opportunities
• 71.3 Biologics Market In 2028 - Growth Strategies
  • 71.3.1 Market Trend Based Strategies
  • 71.3.2 Competitor Strategies

72. Appendix

• 72.1. Abbreviations
• 72.2. Currencies
• 72.3. Historic And Forecast Inflation Rates
• 72.4. Research Inquiries
• 72.5. The Business Research Company
• 72.6. Copyright And Disclaimer